Global Leukocyte Surface Antigen CD47 Market Growth 2022-2028
The report requires updating with new data and is sent in 48 hours after order is placed.
As the global economy mends, the 2021 growth of Leukocyte Surface Antigen CD47 will have significant change from previous year. According to our (LP Information) latest study, the global Leukocyte Surface Antigen CD47 market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Leukocyte Surface Antigen CD47 market size will reach USD million in 2028, growing at a CAGR of % over the analysis period.
The United States Leukocyte Surface Antigen CD47 market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Leukocyte Surface Antigen CD47 market, reaching US$ million by the year 2028. As for the Europe Leukocyte Surface Antigen CD47 landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Leukocyte Surface Antigen CD47 players cover Aurigene Discovery Technologies Ltd, Celgene Corp, Forty Seven Inc, and Surface Oncology Inc, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Leukocyte Surface Antigen CD47 market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
As the global economy mends, the 2021 growth of Leukocyte Surface Antigen CD47 will have significant change from previous year. According to our (LP Information) latest study, the global Leukocyte Surface Antigen CD47 market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Leukocyte Surface Antigen CD47 market size will reach USD million in 2028, growing at a CAGR of % over the analysis period.
The United States Leukocyte Surface Antigen CD47 market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Leukocyte Surface Antigen CD47 market, reaching US$ million by the year 2028. As for the Europe Leukocyte Surface Antigen CD47 landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Leukocyte Surface Antigen CD47 players cover Aurigene Discovery Technologies Ltd, Celgene Corp, Forty Seven Inc, and Surface Oncology Inc, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Leukocyte Surface Antigen CD47 market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
- B-6H12
- ALX-148
- CC-90002
- PSTx-23
- Others
- Lymphoma
- Ovarian Cancer
- Ischemia Reperfusion Injury
- Kindney Transplant Rejection
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Aurigene Discovery Technologies Ltd
- Celgene Corp
- Forty Seven Inc
- Surface Oncology Inc
- Trillium Therapeutics Inc
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Leukocyte Surface Antigen CD47 Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Leukocyte Surface Antigen CD47 by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Leukocyte Surface Antigen CD47 by Country/Region, 2017, 2022 & 2028
2.2 Leukocyte Surface Antigen CD47 Segment by Type
2.2.1 B-6H12
2.2.2 ALX-148
2.2.3 CC-90002
2.2.4 PSTx-23
2.2.5 Others
2.3 Leukocyte Surface Antigen CD47 Sales by Type
2.3.1 Global Leukocyte Surface Antigen CD47 Sales Market Share by Type (2017-2022)
2.3.2 Global Leukocyte Surface Antigen CD47 Revenue and Market Share by Type (2017-2022)
2.3.3 Global Leukocyte Surface Antigen CD47 Sale Price by Type (2017-2022)
2.4 Leukocyte Surface Antigen CD47 Segment by Application
2.4.1 Lymphoma
2.4.2 Ovarian Cancer
2.4.3 Ischemia Reperfusion Injury
2.4.4 Kindney Transplant Rejection
2.4.5 Others
2.5 Leukocyte Surface Antigen CD47 Sales by Application
2.5.1 Global Leukocyte Surface Antigen CD47 Sale Market Share by Application (2017-2022)
2.5.2 Global Leukocyte Surface Antigen CD47 Revenue and Market Share by Application (2017-2022)
2.5.3 Global Leukocyte Surface Antigen CD47 Sale Price by Application (2017-2022)
3 GLOBAL LEUKOCYTE SURFACE ANTIGEN CD47 BY COMPANY
3.1 Global Leukocyte Surface Antigen CD47 Breakdown Data by Company
3.1.1 Global Leukocyte Surface Antigen CD47 Annual Sales by Company (2020-2022)
3.1.2 Global Leukocyte Surface Antigen CD47 Sales Market Share by Company (2020-2022)
3.2 Global Leukocyte Surface Antigen CD47 Annual Revenue by Company (2020-2022)
3.2.1 Global Leukocyte Surface Antigen CD47 Revenue by Company (2020-2022)
3.2.2 Global Leukocyte Surface Antigen CD47 Revenue Market Share by Company (2020-2022)
3.3 Global Leukocyte Surface Antigen CD47 Sale Price by Company
3.4 Key Manufacturers Leukocyte Surface Antigen CD47 Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Leukocyte Surface Antigen CD47 Product Location Distribution
3.4.2 Players Leukocyte Surface Antigen CD47 Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR LEUKOCYTE SURFACE ANTIGEN CD47 BY GEOGRAPHIC REGION
4.1 World Historic Leukocyte Surface Antigen CD47 Market Size by Geographic Region (2017-2022)
4.1.1 Global Leukocyte Surface Antigen CD47 Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Leukocyte Surface Antigen CD47 Annual Revenue by Geographic Region
4.2 World Historic Leukocyte Surface Antigen CD47 Market Size by Country/Region (2017-2022)
4.2.1 Global Leukocyte Surface Antigen CD47 Annual Sales by Country/Region (2017-2022)
4.2.2 Global Leukocyte Surface Antigen CD47 Annual Revenue by Country/Region
4.3 Americas Leukocyte Surface Antigen CD47 Sales Growth
4.4 APAC Leukocyte Surface Antigen CD47 Sales Growth
4.5 Europe Leukocyte Surface Antigen CD47 Sales Growth
4.6 Middle East & Africa Leukocyte Surface Antigen CD47 Sales Growth
5 AMERICAS
5.1 Americas Leukocyte Surface Antigen CD47 Sales by Country
5.1.1 Americas Leukocyte Surface Antigen CD47 Sales by Country (2017-2022)
5.1.2 Americas Leukocyte Surface Antigen CD47 Revenue by Country (2017-2022)
5.2 Americas Leukocyte Surface Antigen CD47 Sales by Type
5.3 Americas Leukocyte Surface Antigen CD47 Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Leukocyte Surface Antigen CD47 Sales by Region
6.1.1 APAC Leukocyte Surface Antigen CD47 Sales by Region (2017-2022)
6.1.2 APAC Leukocyte Surface Antigen CD47 Revenue by Region (2017-2022)
6.2 APAC Leukocyte Surface Antigen CD47 Sales by Type
6.3 APAC Leukocyte Surface Antigen CD47 Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Leukocyte Surface Antigen CD47 by Country
7.1.1 Europe Leukocyte Surface Antigen CD47 Sales by Country (2017-2022)
7.1.2 Europe Leukocyte Surface Antigen CD47 Revenue by Country (2017-2022)
7.2 Europe Leukocyte Surface Antigen CD47 Sales by Type
7.3 Europe Leukocyte Surface Antigen CD47 Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Leukocyte Surface Antigen CD47 by Country
8.1.1 Middle East & Africa Leukocyte Surface Antigen CD47 Sales by Country (2017-2022)
8.1.2 Middle East & Africa Leukocyte Surface Antigen CD47 Revenue by Country (2017-2022)
8.2 Middle East & Africa Leukocyte Surface Antigen CD47 Sales by Type
8.3 Middle East & Africa Leukocyte Surface Antigen CD47 Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Leukocyte Surface Antigen CD47
10.3 Manufacturing Process Analysis of Leukocyte Surface Antigen CD47
10.4 Industry Chain Structure of Leukocyte Surface Antigen CD47
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Leukocyte Surface Antigen CD47 Distributors
11.3 Leukocyte Surface Antigen CD47 Customer
12 WORLD FORECAST REVIEW FOR LEUKOCYTE SURFACE ANTIGEN CD47 BY GEOGRAPHIC REGION
12.1 Global Leukocyte Surface Antigen CD47 Market Size Forecast by Region
12.1.1 Global Leukocyte Surface Antigen CD47 Forecast by Region (2023-2028)
12.1.2 Global Leukocyte Surface Antigen CD47 Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Leukocyte Surface Antigen CD47 Forecast by Type
12.7 Global Leukocyte Surface Antigen CD47 Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Aurigene Discovery Technologies Ltd
13.1.1 Aurigene Discovery Technologies Ltd Company Information
13.1.2 Aurigene Discovery Technologies Ltd Leukocyte Surface Antigen CD47 Product Offered
13.1.3 Aurigene Discovery Technologies Ltd Leukocyte Surface Antigen CD47 Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Aurigene Discovery Technologies Ltd Main Business Overview
13.1.5 Aurigene Discovery Technologies Ltd Latest Developments
13.2 Celgene Corp
13.2.1 Celgene Corp Company Information
13.2.2 Celgene Corp Leukocyte Surface Antigen CD47 Product Offered
13.2.3 Celgene Corp Leukocyte Surface Antigen CD47 Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 Celgene Corp Main Business Overview
13.2.5 Celgene Corp Latest Developments
13.3 Forty Seven Inc
13.3.1 Forty Seven Inc Company Information
13.3.2 Forty Seven Inc Leukocyte Surface Antigen CD47 Product Offered
13.3.3 Forty Seven Inc Leukocyte Surface Antigen CD47 Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Forty Seven Inc Main Business Overview
13.3.5 Forty Seven Inc Latest Developments
13.4 Surface Oncology Inc
13.4.1 Surface Oncology Inc Company Information
13.4.2 Surface Oncology Inc Leukocyte Surface Antigen CD47 Product Offered
13.4.3 Surface Oncology Inc Leukocyte Surface Antigen CD47 Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Surface Oncology Inc Main Business Overview
13.4.5 Surface Oncology Inc Latest Developments
13.5 Trillium Therapeutics Inc
13.5.1 Trillium Therapeutics Inc Company Information
13.5.2 Trillium Therapeutics Inc Leukocyte Surface Antigen CD47 Product Offered
13.5.3 Trillium Therapeutics Inc Leukocyte Surface Antigen CD47 Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 Trillium Therapeutics Inc Main Business Overview
13.5.5 Trillium Therapeutics Inc Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Leukocyte Surface Antigen CD47 Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Leukocyte Surface Antigen CD47 by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Leukocyte Surface Antigen CD47 by Country/Region, 2017, 2022 & 2028
2.2 Leukocyte Surface Antigen CD47 Segment by Type
2.2.1 B-6H12
2.2.2 ALX-148
2.2.3 CC-90002
2.2.4 PSTx-23
2.2.5 Others
2.3 Leukocyte Surface Antigen CD47 Sales by Type
2.3.1 Global Leukocyte Surface Antigen CD47 Sales Market Share by Type (2017-2022)
2.3.2 Global Leukocyte Surface Antigen CD47 Revenue and Market Share by Type (2017-2022)
2.3.3 Global Leukocyte Surface Antigen CD47 Sale Price by Type (2017-2022)
2.4 Leukocyte Surface Antigen CD47 Segment by Application
2.4.1 Lymphoma
2.4.2 Ovarian Cancer
2.4.3 Ischemia Reperfusion Injury
2.4.4 Kindney Transplant Rejection
2.4.5 Others
2.5 Leukocyte Surface Antigen CD47 Sales by Application
2.5.1 Global Leukocyte Surface Antigen CD47 Sale Market Share by Application (2017-2022)
2.5.2 Global Leukocyte Surface Antigen CD47 Revenue and Market Share by Application (2017-2022)
2.5.3 Global Leukocyte Surface Antigen CD47 Sale Price by Application (2017-2022)
3 GLOBAL LEUKOCYTE SURFACE ANTIGEN CD47 BY COMPANY
3.1 Global Leukocyte Surface Antigen CD47 Breakdown Data by Company
3.1.1 Global Leukocyte Surface Antigen CD47 Annual Sales by Company (2020-2022)
3.1.2 Global Leukocyte Surface Antigen CD47 Sales Market Share by Company (2020-2022)
3.2 Global Leukocyte Surface Antigen CD47 Annual Revenue by Company (2020-2022)
3.2.1 Global Leukocyte Surface Antigen CD47 Revenue by Company (2020-2022)
3.2.2 Global Leukocyte Surface Antigen CD47 Revenue Market Share by Company (2020-2022)
3.3 Global Leukocyte Surface Antigen CD47 Sale Price by Company
3.4 Key Manufacturers Leukocyte Surface Antigen CD47 Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Leukocyte Surface Antigen CD47 Product Location Distribution
3.4.2 Players Leukocyte Surface Antigen CD47 Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR LEUKOCYTE SURFACE ANTIGEN CD47 BY GEOGRAPHIC REGION
4.1 World Historic Leukocyte Surface Antigen CD47 Market Size by Geographic Region (2017-2022)
4.1.1 Global Leukocyte Surface Antigen CD47 Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Leukocyte Surface Antigen CD47 Annual Revenue by Geographic Region
4.2 World Historic Leukocyte Surface Antigen CD47 Market Size by Country/Region (2017-2022)
4.2.1 Global Leukocyte Surface Antigen CD47 Annual Sales by Country/Region (2017-2022)
4.2.2 Global Leukocyte Surface Antigen CD47 Annual Revenue by Country/Region
4.3 Americas Leukocyte Surface Antigen CD47 Sales Growth
4.4 APAC Leukocyte Surface Antigen CD47 Sales Growth
4.5 Europe Leukocyte Surface Antigen CD47 Sales Growth
4.6 Middle East & Africa Leukocyte Surface Antigen CD47 Sales Growth
5 AMERICAS
5.1 Americas Leukocyte Surface Antigen CD47 Sales by Country
5.1.1 Americas Leukocyte Surface Antigen CD47 Sales by Country (2017-2022)
5.1.2 Americas Leukocyte Surface Antigen CD47 Revenue by Country (2017-2022)
5.2 Americas Leukocyte Surface Antigen CD47 Sales by Type
5.3 Americas Leukocyte Surface Antigen CD47 Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Leukocyte Surface Antigen CD47 Sales by Region
6.1.1 APAC Leukocyte Surface Antigen CD47 Sales by Region (2017-2022)
6.1.2 APAC Leukocyte Surface Antigen CD47 Revenue by Region (2017-2022)
6.2 APAC Leukocyte Surface Antigen CD47 Sales by Type
6.3 APAC Leukocyte Surface Antigen CD47 Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Leukocyte Surface Antigen CD47 by Country
7.1.1 Europe Leukocyte Surface Antigen CD47 Sales by Country (2017-2022)
7.1.2 Europe Leukocyte Surface Antigen CD47 Revenue by Country (2017-2022)
7.2 Europe Leukocyte Surface Antigen CD47 Sales by Type
7.3 Europe Leukocyte Surface Antigen CD47 Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Leukocyte Surface Antigen CD47 by Country
8.1.1 Middle East & Africa Leukocyte Surface Antigen CD47 Sales by Country (2017-2022)
8.1.2 Middle East & Africa Leukocyte Surface Antigen CD47 Revenue by Country (2017-2022)
8.2 Middle East & Africa Leukocyte Surface Antigen CD47 Sales by Type
8.3 Middle East & Africa Leukocyte Surface Antigen CD47 Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Leukocyte Surface Antigen CD47
10.3 Manufacturing Process Analysis of Leukocyte Surface Antigen CD47
10.4 Industry Chain Structure of Leukocyte Surface Antigen CD47
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Leukocyte Surface Antigen CD47 Distributors
11.3 Leukocyte Surface Antigen CD47 Customer
12 WORLD FORECAST REVIEW FOR LEUKOCYTE SURFACE ANTIGEN CD47 BY GEOGRAPHIC REGION
12.1 Global Leukocyte Surface Antigen CD47 Market Size Forecast by Region
12.1.1 Global Leukocyte Surface Antigen CD47 Forecast by Region (2023-2028)
12.1.2 Global Leukocyte Surface Antigen CD47 Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Leukocyte Surface Antigen CD47 Forecast by Type
12.7 Global Leukocyte Surface Antigen CD47 Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Aurigene Discovery Technologies Ltd
13.1.1 Aurigene Discovery Technologies Ltd Company Information
13.1.2 Aurigene Discovery Technologies Ltd Leukocyte Surface Antigen CD47 Product Offered
13.1.3 Aurigene Discovery Technologies Ltd Leukocyte Surface Antigen CD47 Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Aurigene Discovery Technologies Ltd Main Business Overview
13.1.5 Aurigene Discovery Technologies Ltd Latest Developments
13.2 Celgene Corp
13.2.1 Celgene Corp Company Information
13.2.2 Celgene Corp Leukocyte Surface Antigen CD47 Product Offered
13.2.3 Celgene Corp Leukocyte Surface Antigen CD47 Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 Celgene Corp Main Business Overview
13.2.5 Celgene Corp Latest Developments
13.3 Forty Seven Inc
13.3.1 Forty Seven Inc Company Information
13.3.2 Forty Seven Inc Leukocyte Surface Antigen CD47 Product Offered
13.3.3 Forty Seven Inc Leukocyte Surface Antigen CD47 Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Forty Seven Inc Main Business Overview
13.3.5 Forty Seven Inc Latest Developments
13.4 Surface Oncology Inc
13.4.1 Surface Oncology Inc Company Information
13.4.2 Surface Oncology Inc Leukocyte Surface Antigen CD47 Product Offered
13.4.3 Surface Oncology Inc Leukocyte Surface Antigen CD47 Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Surface Oncology Inc Main Business Overview
13.4.5 Surface Oncology Inc Latest Developments
13.5 Trillium Therapeutics Inc
13.5.1 Trillium Therapeutics Inc Company Information
13.5.2 Trillium Therapeutics Inc Leukocyte Surface Antigen CD47 Product Offered
13.5.3 Trillium Therapeutics Inc Leukocyte Surface Antigen CD47 Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 Trillium Therapeutics Inc Main Business Overview
13.5.5 Trillium Therapeutics Inc Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Leukocyte Surface Antigen CD47 Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Leukocyte Surface Antigen CD47 Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of B-6H12
Table 4. Major Players of ALX-148
Table 5. Major Players of CC-90002
Table 6. Major Players of PSTx-23
Table 7. Major Players of Others
Table 8. Global Leukocyte Surface Antigen CD47 Sales by Type (2017-2022) & (K Pcs)
Table 9. Global Leukocyte Surface Antigen CD47 Sales Market Share by Type (2017-2022)
Table 10. Global Leukocyte Surface Antigen CD47 Revenue by Type (2017-2022) & ($ million)
Table 11. Global Leukocyte Surface Antigen CD47 Revenue Market Share by Type (2017-2022)
Table 12. Global Leukocyte Surface Antigen CD47 Sale Price by Type (2017-2022) & (USD/Pcs)
Table 13. Global Leukocyte Surface Antigen CD47 Sales by Application (2017-2022) & (K Pcs)
Table 14. Global Leukocyte Surface Antigen CD47 Sales Market Share by Application (2017-2022)
Table 15. Global Leukocyte Surface Antigen CD47 Revenue by Application (2017-2022)
Table 16. Global Leukocyte Surface Antigen CD47 Revenue Market Share by Application (2017-2022)
Table 17. Global Leukocyte Surface Antigen CD47 Sale Price by Application (2017-2022) & (USD/Pcs)
Table 18. Global Leukocyte Surface Antigen CD47 Sales by Company (2020-2022) & (K Pcs)
Table 19. Global Leukocyte Surface Antigen CD47 Sales Market Share by Company (2020-2022)
Table 20. Global Leukocyte Surface Antigen CD47 Revenue by Company (2020-2022) ($ Millions)
Table 21. Global Leukocyte Surface Antigen CD47 Revenue Market Share by Company (2020-2022)
Table 22. Global Leukocyte Surface Antigen CD47 Sale Price by Company (2020-2022) & (USD/Pcs)
Table 23. Key Manufacturers Leukocyte Surface Antigen CD47 Producing Area Distribution and Sales Area
Table 24. Players Leukocyte Surface Antigen CD47 Products Offered
Table 25. Leukocyte Surface Antigen CD47 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 26. New Products and Potential Entrants
Table 27. Mergers & Acquisitions, Expansion
Table 28. Global Leukocyte Surface Antigen CD47 Sales by Geographic Region (2017-2022) & (K Pcs)
Table 29. Global Leukocyte Surface Antigen CD47 Sales Market Share Geographic Region (2017-2022)
Table 30. Global Leukocyte Surface Antigen CD47 Revenue by Geographic Region (2017-2022) & ($ millions)
Table 31. Global Leukocyte Surface Antigen CD47 Revenue Market Share by Geographic Region (2017-2022)
Table 32. Global Leukocyte Surface Antigen CD47 Sales by Country/Region (2017-2022) & (K Pcs)
Table 33. Global Leukocyte Surface Antigen CD47 Sales Market Share by Country/Region (2017-2022)
Table 34. Global Leukocyte Surface Antigen CD47 Revenue by Country/Region (2017-2022) & ($ millions)
Table 35. Global Leukocyte Surface Antigen CD47 Revenue Market Share by Country/Region (2017-2022)
Table 36. Americas Leukocyte Surface Antigen CD47 Sales by Country (2017-2022) & (K Pcs)
Table 37. Americas Leukocyte Surface Antigen CD47 Sales Market Share by Country (2017-2022)
Table 38. Americas Leukocyte Surface Antigen CD47 Revenue by Country (2017-2022) & ($ Millions)
Table 39. Americas Leukocyte Surface Antigen CD47 Revenue Market Share by Country (2017-2022)
Table 40. Americas Leukocyte Surface Antigen CD47 Sales by Type (2017-2022) & (K Pcs)
Table 41. Americas Leukocyte Surface Antigen CD47 Sales Market Share by Type (2017-2022)
Table 42. Americas Leukocyte Surface Antigen CD47 Sales by Application (2017-2022) & (K Pcs)
Table 43. Americas Leukocyte Surface Antigen CD47 Sales Market Share by Application (2017-2022)
Table 44. APAC Leukocyte Surface Antigen CD47 Sales by Region (2017-2022) & (K Pcs)
Table 45. APAC Leukocyte Surface Antigen CD47 Sales Market Share by Region (2017-2022)
Table 46. APAC Leukocyte Surface Antigen CD47 Revenue by Region (2017-2022) & ($ Millions)
Table 47. APAC Leukocyte Surface Antigen CD47 Revenue Market Share by Region (2017-2022)
Table 48. APAC Leukocyte Surface Antigen CD47 Sales by Type (2017-2022) & (K Pcs)
Table 49. APAC Leukocyte Surface Antigen CD47 Sales Market Share by Type (2017-2022)
Table 50. APAC Leukocyte Surface Antigen CD47 Sales by Application (2017-2022) & (K Pcs)
Table 51. APAC Leukocyte Surface Antigen CD47 Sales Market Share by Application (2017-2022)
Table 52. Europe Leukocyte Surface Antigen CD47 Sales by Country (2017-2022) & (K Pcs)
Table 53. Europe Leukocyte Surface Antigen CD47 Sales Market Share by Country (2017-2022)
Table 54. Europe Leukocyte Surface Antigen CD47 Revenue by Country (2017-2022) & ($ Millions)
Table 55. Europe Leukocyte Surface Antigen CD47 Revenue Market Share by Country (2017-2022)
Table 56. Europe Leukocyte Surface Antigen CD47 Sales by Type (2017-2022) & (K Pcs)
Table 57. Europe Leukocyte Surface Antigen CD47 Sales Market Share by Type (2017-2022)
Table 58. Europe Leukocyte Surface Antigen CD47 Sales by Application (2017-2022) & (K Pcs)
Table 59. Europe Leukocyte Surface Antigen CD47 Sales Market Share by Application (2017-2022)
Table 60. Middle East & Africa Leukocyte Surface Antigen CD47 Sales by Country (2017-2022) & (K Pcs)
Table 61. Middle East & Africa Leukocyte Surface Antigen CD47 Sales Market Share by Country (2017-2022)
Table 62. Middle East & Africa Leukocyte Surface Antigen CD47 Revenue by Country (2017-2022) & ($ Millions)
Table 63. Middle East & Africa Leukocyte Surface Antigen CD47 Revenue Market Share by Country (2017-2022)
Table 64. Middle East & Africa Leukocyte Surface Antigen CD47 Sales by Type (2017-2022) & (K Pcs)
Table 65. Middle East & Africa Leukocyte Surface Antigen CD47 Sales Market Share by Type (2017-2022)
Table 66. Middle East & Africa Leukocyte Surface Antigen CD47 Sales by Application (2017-2022) & (K Pcs)
Table 67. Middle East & Africa Leukocyte Surface Antigen CD47 Sales Market Share by Application (2017-2022)
Table 68. Key Market Drivers & Growth Opportunities of Leukocyte Surface Antigen CD47
Table 69. Key Market Challenges & Risks of Leukocyte Surface Antigen CD47
Table 70. Key Industry Trends of Leukocyte Surface Antigen CD47
Table 71. Leukocyte Surface Antigen CD47 Raw Material
Table 72. Key Suppliers of Raw Materials
Table 73. Leukocyte Surface Antigen CD47 Distributors List
Table 74. Leukocyte Surface Antigen CD47 Customer List
Table 75. Global Leukocyte Surface Antigen CD47 Sales Forecast by Region (2023-2028) & (K Pcs)
Table 76. Global Leukocyte Surface Antigen CD47 Sales Market Forecast by Region
Table 77. Global Leukocyte Surface Antigen CD47 Revenue Forecast by Region (2023-2028) & ($ millions)
Table 78. Global Leukocyte Surface Antigen CD47 Revenue Market Share Forecast by Region (2023-2028)
Table 79. Americas Leukocyte Surface Antigen CD47 Sales Forecast by Country (2023-2028) & (K Pcs)
Table 80. Americas Leukocyte Surface Antigen CD47 Revenue Forecast by Country (2023-2028) & ($ millions)
Table 81. APAC Leukocyte Surface Antigen CD47 Sales Forecast by Region (2023-2028) & (K Pcs)
Table 82. APAC Leukocyte Surface Antigen CD47 Revenue Forecast by Region (2023-2028) & ($ millions)
Table 83. Europe Leukocyte Surface Antigen CD47 Sales Forecast by Country (2023-2028) & (K Pcs)
Table 84. Europe Leukocyte Surface Antigen CD47 Revenue Forecast by Country (2023-2028) & ($ millions)
Table 85. Middle East & Africa Leukocyte Surface Antigen CD47 Sales Forecast by Country (2023-2028) & (K Pcs)
Table 86. Middle East & Africa Leukocyte Surface Antigen CD47 Revenue Forecast by Country (2023-2028) & ($ millions)
Table 87. Global Leukocyte Surface Antigen CD47 Sales Forecast by Type (2023-2028) & (K Pcs)
Table 88. Global Leukocyte Surface Antigen CD47 Sales Market Share Forecast by Type (2023-2028)
Table 89. Global Leukocyte Surface Antigen CD47 Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 90. Global Leukocyte Surface Antigen CD47 Revenue Market Share Forecast by Type (2023-2028)
Table 91. Global Leukocyte Surface Antigen CD47 Sales Forecast by Application (2023-2028) & (K Pcs)
Table 92. Global Leukocyte Surface Antigen CD47 Sales Market Share Forecast by Application (2023-2028)
Table 93. Global Leukocyte Surface Antigen CD47 Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 94. Global Leukocyte Surface Antigen CD47 Revenue Market Share Forecast by Application (2023-2028)
Table 95. Aurigene Discovery Technologies Ltd Basic Information, Leukocyte Surface Antigen CD47 Manufacturing Base, Sales Area and Its Competitors
Table 96. Aurigene Discovery Technologies Ltd Leukocyte Surface Antigen CD47 Product Offered
Table 97. Aurigene Discovery Technologies Ltd Leukocyte Surface Antigen CD47 Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 98. Aurigene Discovery Technologies Ltd Main Business
Table 99. Aurigene Discovery Technologies Ltd Latest Developments
Table 100. Celgene Corp Basic Information, Leukocyte Surface Antigen CD47 Manufacturing Base, Sales Area and Its Competitors
Table 101. Celgene Corp Leukocyte Surface Antigen CD47 Product Offered
Table 102. Celgene Corp Leukocyte Surface Antigen CD47 Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 103. Celgene Corp Main Business
Table 104. Celgene Corp Latest Developments
Table 105. Forty Seven Inc Basic Information, Leukocyte Surface Antigen CD47 Manufacturing Base, Sales Area and Its Competitors
Table 106. Forty Seven Inc Leukocyte Surface Antigen CD47 Product Offered
Table 107. Forty Seven Inc Leukocyte Surface Antigen CD47 Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 108. Forty Seven Inc Main Business
Table 109. Forty Seven Inc Latest Developments
Table 110. Surface Oncology Inc Basic Information, Leukocyte Surface Antigen CD47 Manufacturing Base, Sales Area and Its Competitors
Table 111. Surface Oncology Inc Leukocyte Surface Antigen CD47 Product Offered
Table 112. Surface Oncology Inc Leukocyte Surface Antigen CD47 Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 113. Surface Oncology Inc Main Business
Table 114. Surface Oncology Inc Latest Developments
Table 115. Trillium Therapeutics Inc Basic Information, Leukocyte Surface Antigen CD47 Manufacturing Base, Sales Area and Its Competitors
Table 116. Trillium Therapeutics Inc Leukocyte Surface Antigen CD47 Product Offered
Table 117. Trillium Therapeutics Inc Leukocyte Surface Antigen CD47 Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 118. Trillium Therapeutics Inc Main Business
Table 119. Trillium Therapeutics Inc Latest Developments
Table 1. Leukocyte Surface Antigen CD47 Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Leukocyte Surface Antigen CD47 Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of B-6H12
Table 4. Major Players of ALX-148
Table 5. Major Players of CC-90002
Table 6. Major Players of PSTx-23
Table 7. Major Players of Others
Table 8. Global Leukocyte Surface Antigen CD47 Sales by Type (2017-2022) & (K Pcs)
Table 9. Global Leukocyte Surface Antigen CD47 Sales Market Share by Type (2017-2022)
Table 10. Global Leukocyte Surface Antigen CD47 Revenue by Type (2017-2022) & ($ million)
Table 11. Global Leukocyte Surface Antigen CD47 Revenue Market Share by Type (2017-2022)
Table 12. Global Leukocyte Surface Antigen CD47 Sale Price by Type (2017-2022) & (USD/Pcs)
Table 13. Global Leukocyte Surface Antigen CD47 Sales by Application (2017-2022) & (K Pcs)
Table 14. Global Leukocyte Surface Antigen CD47 Sales Market Share by Application (2017-2022)
Table 15. Global Leukocyte Surface Antigen CD47 Revenue by Application (2017-2022)
Table 16. Global Leukocyte Surface Antigen CD47 Revenue Market Share by Application (2017-2022)
Table 17. Global Leukocyte Surface Antigen CD47 Sale Price by Application (2017-2022) & (USD/Pcs)
Table 18. Global Leukocyte Surface Antigen CD47 Sales by Company (2020-2022) & (K Pcs)
Table 19. Global Leukocyte Surface Antigen CD47 Sales Market Share by Company (2020-2022)
Table 20. Global Leukocyte Surface Antigen CD47 Revenue by Company (2020-2022) ($ Millions)
Table 21. Global Leukocyte Surface Antigen CD47 Revenue Market Share by Company (2020-2022)
Table 22. Global Leukocyte Surface Antigen CD47 Sale Price by Company (2020-2022) & (USD/Pcs)
Table 23. Key Manufacturers Leukocyte Surface Antigen CD47 Producing Area Distribution and Sales Area
Table 24. Players Leukocyte Surface Antigen CD47 Products Offered
Table 25. Leukocyte Surface Antigen CD47 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 26. New Products and Potential Entrants
Table 27. Mergers & Acquisitions, Expansion
Table 28. Global Leukocyte Surface Antigen CD47 Sales by Geographic Region (2017-2022) & (K Pcs)
Table 29. Global Leukocyte Surface Antigen CD47 Sales Market Share Geographic Region (2017-2022)
Table 30. Global Leukocyte Surface Antigen CD47 Revenue by Geographic Region (2017-2022) & ($ millions)
Table 31. Global Leukocyte Surface Antigen CD47 Revenue Market Share by Geographic Region (2017-2022)
Table 32. Global Leukocyte Surface Antigen CD47 Sales by Country/Region (2017-2022) & (K Pcs)
Table 33. Global Leukocyte Surface Antigen CD47 Sales Market Share by Country/Region (2017-2022)
Table 34. Global Leukocyte Surface Antigen CD47 Revenue by Country/Region (2017-2022) & ($ millions)
Table 35. Global Leukocyte Surface Antigen CD47 Revenue Market Share by Country/Region (2017-2022)
Table 36. Americas Leukocyte Surface Antigen CD47 Sales by Country (2017-2022) & (K Pcs)
Table 37. Americas Leukocyte Surface Antigen CD47 Sales Market Share by Country (2017-2022)
Table 38. Americas Leukocyte Surface Antigen CD47 Revenue by Country (2017-2022) & ($ Millions)
Table 39. Americas Leukocyte Surface Antigen CD47 Revenue Market Share by Country (2017-2022)
Table 40. Americas Leukocyte Surface Antigen CD47 Sales by Type (2017-2022) & (K Pcs)
Table 41. Americas Leukocyte Surface Antigen CD47 Sales Market Share by Type (2017-2022)
Table 42. Americas Leukocyte Surface Antigen CD47 Sales by Application (2017-2022) & (K Pcs)
Table 43. Americas Leukocyte Surface Antigen CD47 Sales Market Share by Application (2017-2022)
Table 44. APAC Leukocyte Surface Antigen CD47 Sales by Region (2017-2022) & (K Pcs)
Table 45. APAC Leukocyte Surface Antigen CD47 Sales Market Share by Region (2017-2022)
Table 46. APAC Leukocyte Surface Antigen CD47 Revenue by Region (2017-2022) & ($ Millions)
Table 47. APAC Leukocyte Surface Antigen CD47 Revenue Market Share by Region (2017-2022)
Table 48. APAC Leukocyte Surface Antigen CD47 Sales by Type (2017-2022) & (K Pcs)
Table 49. APAC Leukocyte Surface Antigen CD47 Sales Market Share by Type (2017-2022)
Table 50. APAC Leukocyte Surface Antigen CD47 Sales by Application (2017-2022) & (K Pcs)
Table 51. APAC Leukocyte Surface Antigen CD47 Sales Market Share by Application (2017-2022)
Table 52. Europe Leukocyte Surface Antigen CD47 Sales by Country (2017-2022) & (K Pcs)
Table 53. Europe Leukocyte Surface Antigen CD47 Sales Market Share by Country (2017-2022)
Table 54. Europe Leukocyte Surface Antigen CD47 Revenue by Country (2017-2022) & ($ Millions)
Table 55. Europe Leukocyte Surface Antigen CD47 Revenue Market Share by Country (2017-2022)
Table 56. Europe Leukocyte Surface Antigen CD47 Sales by Type (2017-2022) & (K Pcs)
Table 57. Europe Leukocyte Surface Antigen CD47 Sales Market Share by Type (2017-2022)
Table 58. Europe Leukocyte Surface Antigen CD47 Sales by Application (2017-2022) & (K Pcs)
Table 59. Europe Leukocyte Surface Antigen CD47 Sales Market Share by Application (2017-2022)
Table 60. Middle East & Africa Leukocyte Surface Antigen CD47 Sales by Country (2017-2022) & (K Pcs)
Table 61. Middle East & Africa Leukocyte Surface Antigen CD47 Sales Market Share by Country (2017-2022)
Table 62. Middle East & Africa Leukocyte Surface Antigen CD47 Revenue by Country (2017-2022) & ($ Millions)
Table 63. Middle East & Africa Leukocyte Surface Antigen CD47 Revenue Market Share by Country (2017-2022)
Table 64. Middle East & Africa Leukocyte Surface Antigen CD47 Sales by Type (2017-2022) & (K Pcs)
Table 65. Middle East & Africa Leukocyte Surface Antigen CD47 Sales Market Share by Type (2017-2022)
Table 66. Middle East & Africa Leukocyte Surface Antigen CD47 Sales by Application (2017-2022) & (K Pcs)
Table 67. Middle East & Africa Leukocyte Surface Antigen CD47 Sales Market Share by Application (2017-2022)
Table 68. Key Market Drivers & Growth Opportunities of Leukocyte Surface Antigen CD47
Table 69. Key Market Challenges & Risks of Leukocyte Surface Antigen CD47
Table 70. Key Industry Trends of Leukocyte Surface Antigen CD47
Table 71. Leukocyte Surface Antigen CD47 Raw Material
Table 72. Key Suppliers of Raw Materials
Table 73. Leukocyte Surface Antigen CD47 Distributors List
Table 74. Leukocyte Surface Antigen CD47 Customer List
Table 75. Global Leukocyte Surface Antigen CD47 Sales Forecast by Region (2023-2028) & (K Pcs)
Table 76. Global Leukocyte Surface Antigen CD47 Sales Market Forecast by Region
Table 77. Global Leukocyte Surface Antigen CD47 Revenue Forecast by Region (2023-2028) & ($ millions)
Table 78. Global Leukocyte Surface Antigen CD47 Revenue Market Share Forecast by Region (2023-2028)
Table 79. Americas Leukocyte Surface Antigen CD47 Sales Forecast by Country (2023-2028) & (K Pcs)
Table 80. Americas Leukocyte Surface Antigen CD47 Revenue Forecast by Country (2023-2028) & ($ millions)
Table 81. APAC Leukocyte Surface Antigen CD47 Sales Forecast by Region (2023-2028) & (K Pcs)
Table 82. APAC Leukocyte Surface Antigen CD47 Revenue Forecast by Region (2023-2028) & ($ millions)
Table 83. Europe Leukocyte Surface Antigen CD47 Sales Forecast by Country (2023-2028) & (K Pcs)
Table 84. Europe Leukocyte Surface Antigen CD47 Revenue Forecast by Country (2023-2028) & ($ millions)
Table 85. Middle East & Africa Leukocyte Surface Antigen CD47 Sales Forecast by Country (2023-2028) & (K Pcs)
Table 86. Middle East & Africa Leukocyte Surface Antigen CD47 Revenue Forecast by Country (2023-2028) & ($ millions)
Table 87. Global Leukocyte Surface Antigen CD47 Sales Forecast by Type (2023-2028) & (K Pcs)
Table 88. Global Leukocyte Surface Antigen CD47 Sales Market Share Forecast by Type (2023-2028)
Table 89. Global Leukocyte Surface Antigen CD47 Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 90. Global Leukocyte Surface Antigen CD47 Revenue Market Share Forecast by Type (2023-2028)
Table 91. Global Leukocyte Surface Antigen CD47 Sales Forecast by Application (2023-2028) & (K Pcs)
Table 92. Global Leukocyte Surface Antigen CD47 Sales Market Share Forecast by Application (2023-2028)
Table 93. Global Leukocyte Surface Antigen CD47 Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 94. Global Leukocyte Surface Antigen CD47 Revenue Market Share Forecast by Application (2023-2028)
Table 95. Aurigene Discovery Technologies Ltd Basic Information, Leukocyte Surface Antigen CD47 Manufacturing Base, Sales Area and Its Competitors
Table 96. Aurigene Discovery Technologies Ltd Leukocyte Surface Antigen CD47 Product Offered
Table 97. Aurigene Discovery Technologies Ltd Leukocyte Surface Antigen CD47 Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 98. Aurigene Discovery Technologies Ltd Main Business
Table 99. Aurigene Discovery Technologies Ltd Latest Developments
Table 100. Celgene Corp Basic Information, Leukocyte Surface Antigen CD47 Manufacturing Base, Sales Area and Its Competitors
Table 101. Celgene Corp Leukocyte Surface Antigen CD47 Product Offered
Table 102. Celgene Corp Leukocyte Surface Antigen CD47 Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 103. Celgene Corp Main Business
Table 104. Celgene Corp Latest Developments
Table 105. Forty Seven Inc Basic Information, Leukocyte Surface Antigen CD47 Manufacturing Base, Sales Area and Its Competitors
Table 106. Forty Seven Inc Leukocyte Surface Antigen CD47 Product Offered
Table 107. Forty Seven Inc Leukocyte Surface Antigen CD47 Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 108. Forty Seven Inc Main Business
Table 109. Forty Seven Inc Latest Developments
Table 110. Surface Oncology Inc Basic Information, Leukocyte Surface Antigen CD47 Manufacturing Base, Sales Area and Its Competitors
Table 111. Surface Oncology Inc Leukocyte Surface Antigen CD47 Product Offered
Table 112. Surface Oncology Inc Leukocyte Surface Antigen CD47 Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 113. Surface Oncology Inc Main Business
Table 114. Surface Oncology Inc Latest Developments
Table 115. Trillium Therapeutics Inc Basic Information, Leukocyte Surface Antigen CD47 Manufacturing Base, Sales Area and Its Competitors
Table 116. Trillium Therapeutics Inc Leukocyte Surface Antigen CD47 Product Offered
Table 117. Trillium Therapeutics Inc Leukocyte Surface Antigen CD47 Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 118. Trillium Therapeutics Inc Main Business
Table 119. Trillium Therapeutics Inc Latest Developments
LIST OF FIGURES
Figure 1. Picture of Leukocyte Surface Antigen CD47
Figure 2. Leukocyte Surface Antigen CD47 Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Leukocyte Surface Antigen CD47 Sales Growth Rate 2017-2028 (K Pcs)
Figure 7. Global Leukocyte Surface Antigen CD47 Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Leukocyte Surface Antigen CD47 Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of B-6H12
Figure 10. Product Picture of ALX-148
Figure 11. Product Picture of CC-90002
Figure 12. Product Picture of PSTx-23
Figure 13. Product Picture of Others
Figure 14. Global Leukocyte Surface Antigen CD47 Sales Market Share by Type in 2021
Figure 15. Global Leukocyte Surface Antigen CD47 Revenue Market Share by Type (2017-2022)
Figure 16. Leukocyte Surface Antigen CD47 Consumed in Lymphoma
Figure 17. Global Leukocyte Surface Antigen CD47 Market: Lymphoma (2017-2022) & (K Pcs)
Figure 18. Leukocyte Surface Antigen CD47 Consumed in Ovarian Cancer
Figure 19. Global Leukocyte Surface Antigen CD47 Market: Ovarian Cancer (2017-2022) & (K Pcs)
Figure 20. Leukocyte Surface Antigen CD47 Consumed in Ischemia Reperfusion Injury
Figure 21. Global Leukocyte Surface Antigen CD47 Market: Ischemia Reperfusion Injury (2017-2022) & (K Pcs)
Figure 22. Leukocyte Surface Antigen CD47 Consumed in Kindney Transplant Rejection
Figure 23. Global Leukocyte Surface Antigen CD47 Market: Kindney Transplant Rejection (2017-2022) & (K Pcs)
Figure 24. Leukocyte Surface Antigen CD47 Consumed in Others
Figure 25. Global Leukocyte Surface Antigen CD47 Market: Others (2017-2022) & (K Pcs)
Figure 26. Global Leukocyte Surface Antigen CD47 Sales Market Share by Application (2017-2022)
Figure 27. Global Leukocyte Surface Antigen CD47 Revenue Market Share by Application in 2021
Figure 28. Leukocyte Surface Antigen CD47 Revenue Market by Company in 2021 ($ Million)
Figure 29. Global Leukocyte Surface Antigen CD47 Revenue Market Share by Company in 2021
Figure 30. Global Leukocyte Surface Antigen CD47 Sales Market Share by Geographic Region (2017-2022)
Figure 31. Global Leukocyte Surface Antigen CD47 Revenue Market Share by Geographic Region in 2021
Figure 32. Global Leukocyte Surface Antigen CD47 Sales Market Share by Region (2017-2022)
Figure 33. Global Leukocyte Surface Antigen CD47 Revenue Market Share by Country/Region in 2021
Figure 34. Americas Leukocyte Surface Antigen CD47 Sales 2017-2022 (K Pcs)
Figure 35. Americas Leukocyte Surface Antigen CD47 Revenue 2017-2022 ($ Millions)
Figure 36. APAC Leukocyte Surface Antigen CD47 Sales 2017-2022 (K Pcs)
Figure 37. APAC Leukocyte Surface Antigen CD47 Revenue 2017-2022 ($ Millions)
Figure 38. Europe Leukocyte Surface Antigen CD47 Sales 2017-2022 (K Pcs)
Figure 39. Europe Leukocyte Surface Antigen CD47 Revenue 2017-2022 ($ Millions)
Figure 40. Middle East & Africa Leukocyte Surface Antigen CD47 Sales 2017-2022 (K Pcs)
Figure 41. Middle East & Africa Leukocyte Surface Antigen CD47 Revenue 2017-2022 ($ Millions)
Figure 42. Americas Leukocyte Surface Antigen CD47 Sales Market Share by Country in 2021
Figure 43. Americas Leukocyte Surface Antigen CD47 Revenue Market Share by Country in 2021
Figure 44. United States Leukocyte Surface Antigen CD47 Revenue Growth 2017-2022 ($ Millions)
Figure 45. Canada Leukocyte Surface Antigen CD47 Revenue Growth 2017-2022 ($ Millions)
Figure 46. Mexico Leukocyte Surface Antigen CD47 Revenue Growth 2017-2022 ($ Millions)
Figure 47. Brazil Leukocyte Surface Antigen CD47 Revenue Growth 2017-2022 ($ Millions)
Figure 48. APAC Leukocyte Surface Antigen CD47 Sales Market Share by Region in 2021
Figure 49. APAC Leukocyte Surface Antigen CD47 Revenue Market Share by Regions in 2021
Figure 50. China Leukocyte Surface Antigen CD47 Revenue Growth 2017-2022 ($ Millions)
Figure 51. Japan Leukocyte Surface Antigen CD47 Revenue Growth 2017-2022 ($ Millions)
Figure 52. South Korea Leukocyte Surface Antigen CD47 Revenue Growth 2017-2022 ($ Millions)
Figure 53. Southeast Asia Leukocyte Surface Antigen CD47 Revenue Growth 2017-2022 ($ Millions)
Figure 54. India Leukocyte Surface Antigen CD47 Revenue Growth 2017-2022 ($ Millions)
Figure 55. Australia Leukocyte Surface Antigen CD47 Revenue Growth 2017-2022 ($ Millions)
Figure 56. Europe Leukocyte Surface Antigen CD47 Sales Market Share by Country in 2021
Figure 57. Europe Leukocyte Surface Antigen CD47 Revenue Market Share by Country in 2021
Figure 58. Germany Leukocyte Surface Antigen CD47 Revenue Growth 2017-2022 ($ Millions)
Figure 59. France Leukocyte Surface Antigen CD47 Revenue Growth 2017-2022 ($ Millions)
Figure 60. UK Leukocyte Surface Antigen CD47 Revenue Growth 2017-2022 ($ Millions)
Figure 61. Italy Leukocyte Surface Antigen CD47 Revenue Growth 2017-2022 ($ Millions)
Figure 62. Russia Leukocyte Surface Antigen CD47 Revenue Growth 2017-2022 ($ Millions)
Figure 63. Middle East & Africa Leukocyte Surface Antigen CD47 Sales Market Share by Country in 2021
Figure 64. Middle East & Africa Leukocyte Surface Antigen CD47 Revenue Market Share by Country in 2021
Figure 65. Egypt Leukocyte Surface Antigen CD47 Revenue Growth 2017-2022 ($ Millions)
Figure 66. South Africa Leukocyte Surface Antigen CD47 Revenue Growth 2017-2022 ($ Millions)
Figure 67. Israel Leukocyte Surface Antigen CD47 Revenue Growth 2017-2022 ($ Millions)
Figure 68. Turkey Leukocyte Surface Antigen CD47 Revenue Growth 2017-2022 ($ Millions)
Figure 69. GCC Country Leukocyte Surface Antigen CD47 Revenue Growth 2017-2022 ($ Millions)
Figure 70. Manufacturing Cost Structure Analysis of Leukocyte Surface Antigen CD47 in 2021
Figure 71. Manufacturing Process Analysis of Leukocyte Surface Antigen CD47
Figure 72. Industry Chain Structure of Leukocyte Surface Antigen CD47
Figure 73. Channels of Distribution
Figure 74. Distributors Profiles
Figure 1. Picture of Leukocyte Surface Antigen CD47
Figure 2. Leukocyte Surface Antigen CD47 Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Leukocyte Surface Antigen CD47 Sales Growth Rate 2017-2028 (K Pcs)
Figure 7. Global Leukocyte Surface Antigen CD47 Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Leukocyte Surface Antigen CD47 Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of B-6H12
Figure 10. Product Picture of ALX-148
Figure 11. Product Picture of CC-90002
Figure 12. Product Picture of PSTx-23
Figure 13. Product Picture of Others
Figure 14. Global Leukocyte Surface Antigen CD47 Sales Market Share by Type in 2021
Figure 15. Global Leukocyte Surface Antigen CD47 Revenue Market Share by Type (2017-2022)
Figure 16. Leukocyte Surface Antigen CD47 Consumed in Lymphoma
Figure 17. Global Leukocyte Surface Antigen CD47 Market: Lymphoma (2017-2022) & (K Pcs)
Figure 18. Leukocyte Surface Antigen CD47 Consumed in Ovarian Cancer
Figure 19. Global Leukocyte Surface Antigen CD47 Market: Ovarian Cancer (2017-2022) & (K Pcs)
Figure 20. Leukocyte Surface Antigen CD47 Consumed in Ischemia Reperfusion Injury
Figure 21. Global Leukocyte Surface Antigen CD47 Market: Ischemia Reperfusion Injury (2017-2022) & (K Pcs)
Figure 22. Leukocyte Surface Antigen CD47 Consumed in Kindney Transplant Rejection
Figure 23. Global Leukocyte Surface Antigen CD47 Market: Kindney Transplant Rejection (2017-2022) & (K Pcs)
Figure 24. Leukocyte Surface Antigen CD47 Consumed in Others
Figure 25. Global Leukocyte Surface Antigen CD47 Market: Others (2017-2022) & (K Pcs)
Figure 26. Global Leukocyte Surface Antigen CD47 Sales Market Share by Application (2017-2022)
Figure 27. Global Leukocyte Surface Antigen CD47 Revenue Market Share by Application in 2021
Figure 28. Leukocyte Surface Antigen CD47 Revenue Market by Company in 2021 ($ Million)
Figure 29. Global Leukocyte Surface Antigen CD47 Revenue Market Share by Company in 2021
Figure 30. Global Leukocyte Surface Antigen CD47 Sales Market Share by Geographic Region (2017-2022)
Figure 31. Global Leukocyte Surface Antigen CD47 Revenue Market Share by Geographic Region in 2021
Figure 32. Global Leukocyte Surface Antigen CD47 Sales Market Share by Region (2017-2022)
Figure 33. Global Leukocyte Surface Antigen CD47 Revenue Market Share by Country/Region in 2021
Figure 34. Americas Leukocyte Surface Antigen CD47 Sales 2017-2022 (K Pcs)
Figure 35. Americas Leukocyte Surface Antigen CD47 Revenue 2017-2022 ($ Millions)
Figure 36. APAC Leukocyte Surface Antigen CD47 Sales 2017-2022 (K Pcs)
Figure 37. APAC Leukocyte Surface Antigen CD47 Revenue 2017-2022 ($ Millions)
Figure 38. Europe Leukocyte Surface Antigen CD47 Sales 2017-2022 (K Pcs)
Figure 39. Europe Leukocyte Surface Antigen CD47 Revenue 2017-2022 ($ Millions)
Figure 40. Middle East & Africa Leukocyte Surface Antigen CD47 Sales 2017-2022 (K Pcs)
Figure 41. Middle East & Africa Leukocyte Surface Antigen CD47 Revenue 2017-2022 ($ Millions)
Figure 42. Americas Leukocyte Surface Antigen CD47 Sales Market Share by Country in 2021
Figure 43. Americas Leukocyte Surface Antigen CD47 Revenue Market Share by Country in 2021
Figure 44. United States Leukocyte Surface Antigen CD47 Revenue Growth 2017-2022 ($ Millions)
Figure 45. Canada Leukocyte Surface Antigen CD47 Revenue Growth 2017-2022 ($ Millions)
Figure 46. Mexico Leukocyte Surface Antigen CD47 Revenue Growth 2017-2022 ($ Millions)
Figure 47. Brazil Leukocyte Surface Antigen CD47 Revenue Growth 2017-2022 ($ Millions)
Figure 48. APAC Leukocyte Surface Antigen CD47 Sales Market Share by Region in 2021
Figure 49. APAC Leukocyte Surface Antigen CD47 Revenue Market Share by Regions in 2021
Figure 50. China Leukocyte Surface Antigen CD47 Revenue Growth 2017-2022 ($ Millions)
Figure 51. Japan Leukocyte Surface Antigen CD47 Revenue Growth 2017-2022 ($ Millions)
Figure 52. South Korea Leukocyte Surface Antigen CD47 Revenue Growth 2017-2022 ($ Millions)
Figure 53. Southeast Asia Leukocyte Surface Antigen CD47 Revenue Growth 2017-2022 ($ Millions)
Figure 54. India Leukocyte Surface Antigen CD47 Revenue Growth 2017-2022 ($ Millions)
Figure 55. Australia Leukocyte Surface Antigen CD47 Revenue Growth 2017-2022 ($ Millions)
Figure 56. Europe Leukocyte Surface Antigen CD47 Sales Market Share by Country in 2021
Figure 57. Europe Leukocyte Surface Antigen CD47 Revenue Market Share by Country in 2021
Figure 58. Germany Leukocyte Surface Antigen CD47 Revenue Growth 2017-2022 ($ Millions)
Figure 59. France Leukocyte Surface Antigen CD47 Revenue Growth 2017-2022 ($ Millions)
Figure 60. UK Leukocyte Surface Antigen CD47 Revenue Growth 2017-2022 ($ Millions)
Figure 61. Italy Leukocyte Surface Antigen CD47 Revenue Growth 2017-2022 ($ Millions)
Figure 62. Russia Leukocyte Surface Antigen CD47 Revenue Growth 2017-2022 ($ Millions)
Figure 63. Middle East & Africa Leukocyte Surface Antigen CD47 Sales Market Share by Country in 2021
Figure 64. Middle East & Africa Leukocyte Surface Antigen CD47 Revenue Market Share by Country in 2021
Figure 65. Egypt Leukocyte Surface Antigen CD47 Revenue Growth 2017-2022 ($ Millions)
Figure 66. South Africa Leukocyte Surface Antigen CD47 Revenue Growth 2017-2022 ($ Millions)
Figure 67. Israel Leukocyte Surface Antigen CD47 Revenue Growth 2017-2022 ($ Millions)
Figure 68. Turkey Leukocyte Surface Antigen CD47 Revenue Growth 2017-2022 ($ Millions)
Figure 69. GCC Country Leukocyte Surface Antigen CD47 Revenue Growth 2017-2022 ($ Millions)
Figure 70. Manufacturing Cost Structure Analysis of Leukocyte Surface Antigen CD47 in 2021
Figure 71. Manufacturing Process Analysis of Leukocyte Surface Antigen CD47
Figure 72. Industry Chain Structure of Leukocyte Surface Antigen CD47
Figure 73. Channels of Distribution
Figure 74. Distributors Profiles
